ECCEO 7 | PORTO | PORTUGAL | Daily news march 31st
Website
- The ECCEO 7 website is supported by an unrestricted grant from Pfizer
Daily News
- The ECCEO 7 Daily News is supported by an unrestricted grant from Novartis
Bus transfer
- Download the bus transfer timetable
BUS TRANSFER
Today
Next Year
Dear Guest
As Chairman of the Scientific Advisory Committee of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO), I have the great pleasure and privilege to welcome you to the 7th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO7)...
Highlights oF the meeting
The morning session of Friday March 30 was related to osteoarthritis. During the first plenary lecture of the day, Professor Dere reviewed, in front of an important number of attendees, the pre-clinical and clinical data suggesting that anti-osteoporotic agents [bisphosphonates (risedronate, alendronate, zolendronate), estrogens, calcitonin and strontium ranelate] could be of potential interest for the treatment of osteoarthritis(1)...
NOVARTIS TRAVEL GRANT
At the end of the second plenary session of the first day of the Seventh ECCEO meeting, the European Society for Clinical and Economical Aspect of Osteoarthritis and Osteoporosis (ESCEO) had the pleasure to present the recipients of the Novartis Travel Grants 2007. These grants were generously supported by Novartis towards original research of significant value and international relevance in the field of osteoporosis...